Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Payables (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Payables for 10 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables rose 6.5% to $2.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a 6.5% increase, with the full-year FY2024 number at $1.9 million, up 48.98% from a year prior.
  • Payables was $2.2 million for Q3 2025 at KORU Medical Systems, up from $1.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.8 million in Q4 2022 to a low of $1.0 million in Q2 2021.
  • A 5-year average of $1.8 million and a median of $1.9 million in 2021 define the central range for Payables.
  • Peak YoY movement for Payables: soared 177.81% in 2021, then tumbled 54.35% in 2023.
  • KORU Medical Systems' Payables stood at $1.7 million in 2021, then surged by 62.72% to $2.8 million in 2022, then crashed by 54.35% to $1.3 million in 2023, then surged by 48.98% to $1.9 million in 2024, then increased by 14.89% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Payables are $2.2 million (Q3 2025), $1.1 million (Q2 2025), and $2.2 million (Q1 2025).